Protein Discovery, New Objective Ink Co-Marketing Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Protein Discovery and New Objective will co-market each other's proteomics technologies and will develop new products under a new agreement, Protein Discovery said today.

The marketing agreement covers Protein Discovery's GelFree 8100 Fractionation System and New Objectives' PicoFrit nanobore chromatography columns and Digital PicoView nanospray sources.

Protein Discovery said that the combined technologies will give researchers top-down protein analysis with an integrated, standardized workflow for mass spectrometry projects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.